Sort by
Refine Your Search
-
Employer
-
Field
-
of maturity, this technology requires to experiment a change of paradigm to guarantee a sustainable development for the years to come. One pathway to achieve this paradigm shift relies on the development
-
imaging and microscopy-based analysis for drug response validation. Experience in mass spectrometry-based proteomics, transcriptomic and other omics-based workflows, including sample preparation, analysis
-
have familiarity with super-resolution and high-content imaging and microscopy-based analysis for drug response validation. Experience in mass spectrometry-based proteomics, transcriptomic and other
-
to identify novel mediators of cancer cell death. Conduct mechanistic studies to elucidate how candidate genes regulate cancer cell death processes in vitro. Establish and utilize syngeneic mouse models